Manuel M. Mazo Vega from CIMA Universidad de Navarra got one of the Ideas Semilla AECC 2020 from the Spanish Cancer Association. The Microfluidics Cluster UPV/EHU will collaborate in the project which aims at setting up, testing and validating a novel Cardiac Toxicity Device (CTD). This new platform emerges from the combination of the latest microfabrication technology with relevant human induced pluripotent stem cell (hiPSC)-derived cardiomyocytes (CMs).